Bio Special
Biotechnology in 2025 is no longer confined to the laboratory bench. It is curing inherited blood disorders, changing how we prevent HIV, reimagining Alzhe...
December 10, 2025 | Report | By BioPharma APAC Wrap Up 2025
A protocol might specify a cohort defined by inflammatory markers, disease severity, a diagnostic pattern or a particular biological signature — but ...
December 10, 2025 | News | By Tom Stubbs, PHD – CEO of Hurdle.bio
Global pharmaceutical companies are racing to tap China’s new AI-powered biotech platforms to discover drugs faster and cheaper. In 2025, major Weste...
November 27, 2025 | Analysis
Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. canc...
November 21, 2025 | News
Vaxcellbio is betting on the combined power of nanobodies and advanced drug delivery science to push boundaries across ophthalmology and other chronic dise...
November 20, 2025 | Interaction
Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology JSR Life Sciences, a global leader in life sci...
November 14, 2025 | News
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
New tool helps sponsors measure, manage and minimize the environmental impact of research The PPD™ clinical research business of Thermo Fisher Scien...
October 22, 2025 | News
Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...
October 15, 2025 | Interview
BioPharma APAC speaks with Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific, on th...
October 13, 2025 | Expert Insight
As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...
October 06, 2025 | News | By arcilla.fran@biopharmaapac.com
Takeda Pharmaceutical, one of the world’s most globalised pharma companies, has confirmed it will step away from in-house development of its cell and...
October 05, 2025 | News
Cancer care in Southeast Asia stands at a critical crossroads. While awareness of early detection is high, the translation into meaningful action remains p...
October 01, 2025 | Interaction | By arcilla.fran@biopharmaapac.com
Most Read
Bio Jobs
News